HMGB1 has been identified as a biomarker of PAH pathogenesis, with the evidence that HMGB1 levels are highly increased in lungs and serums of PAH patients and positively correlate with disease severity.4, 5, 6. The gene discussed is HMGB1; the disease is pulmonary arterial hypertension.